Ngm Biopharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Ngm Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Ngm Biopharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ngm Biopharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $546k | 343k | 1.59 |
| 2023-12-31 | $62k | 73k | 0.86 |
| 2023-09-30 | $176k | 165k | 1.07 |
| 2023-06-30 | $907k | 350k | 2.59 |
| 2023-03-31 | $317k | 78k | 4.08 |
| 2022-12-31 | $578k | 115k | 5.02 |
| 2022-06-30 | $3.9M | 304k | 12.82 |
| 2022-03-31 | $2.4M | 158k | 15.25 |
| 2021-12-31 | $13M | 721k | 17.71 |
| 2021-09-30 | $18M | 848k | 21.02 |
| 2021-06-30 | $14M | 719k | 19.71 |
| 2021-03-31 | $11M | 388k | 29.03 |
| 2020-12-31 | $5.3M | 176k | 30.30 |
| 2020-09-30 | $868k | 55k | 15.91 |
| 2020-06-30 | $549k | 28k | 19.62 |
| 2020-03-31 | $2.5M | 205k | 12.33 |
| 2019-12-31 | $694k | 38k | 18.49 |
| 2019-09-30 | $326k | 23k | 13.91 |
| 2019-06-30 | $308k | 20k | 15.62 |